Page last updated: 2024-11-04

temozolomide and Pachymeningitis

temozolomide has been researched along with Pachymeningitis in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Temozolomide is a novel, oral, second-generation alkylating agent."6.41Temozolomide in early stages of newly diagnosed malignant glioma and neoplastic meningitis. ( Friedman, HS, 2000)
"Temozolomide is a novel, oral, second-generation alkylating agent."2.41Temozolomide in early stages of newly diagnosed malignant glioma and neoplastic meningitis. ( Friedman, HS, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jicha, GA1
Glantz, J1
Clarke, MJ1
Lehwald, LM1
Russo, DP1
Giannini, C1
Wald, JT1
Uhm, J1
Kumar, N1
Aksamit, AJ1
Wetmore, CJ1
Friedman, HS1

Reviews

1 review available for temozolomide and Pachymeningitis

ArticleYear
Temozolomide in early stages of newly diagnosed malignant glioma and neoplastic meningitis.
    Seminars in oncology, 2000, Volume: 27, Issue:3 Suppl 6

    Topics: Animals; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Clinical Trials as Topic;

2000

Other Studies

1 other study available for temozolomide and Pachymeningitis

ArticleYear
Primary diffuse leptomeningeal gliomatosis.
    European neurology, 2009, Volume: 62, Issue:1

    Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain; Dacarbazine; Diagnosis, Differential; Humans;

2009